Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. (Q53615283)

16 May 2018

title

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. (English)

1 reference

16 May 2018

main subject

sickle-cell disease

0 references

patient

0 references

pulmonary hypertension

1 reference

2

1 reference

16 May 2018

Alan Hinderliter

6

object named as

Alan Hinderliter

1 reference

16 May 2018

author name string

Kenneth I Ataga

1

1 reference

16 May 2018

Susan Jones

3

1 reference

16 May 2018

Oludamilola Olajide

4

1 reference

16 May 2018

Dell Strayhorn

5

1 reference

16 May 2018

Eugene P Orringer

7

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 July 2006

1 reference

16 May 2018

British Journal of Haematology

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 May 2018

volume

134

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

109-115

1 reference

16 May 2018

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Pulmonary hypertension in sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Pathogenesis and treatment of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Causes of death in sickle cell disease: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Gelation of sickle cell hemoglobin in mixtures with normal adult and fetal hemoglobins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

Successful pulmonary thromboendarterectomy in two patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06110.X

10.1111/J.1365-2141.2006.06110.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

16803576

1 reference

16 May 2018